The introduction of kinase inhibitors has significantly impacted the treatment landscape of plexiform neurofibromas (PN) associated with neurofibromatosis type 1 (NF1). In this podcast activity from the 2025 Annual Oncology Meeting, noteworthy data in NF1-PN has been summarized and evaluated by Dr. Amy Armstrong. This activity is AMA/ABS/ANCC/ACPE accredited for one-year.

Launch Date: June 5, 2025

Release Date: June 5, 2025

Expiration Date: May 31, 2026

FACULTY

Amy Armstrong, MD

Assistant Professor of Pediatrics

Division of Hematology/Oncology

Neurofibromatosis (NF) Center

Washington University School of Medicine

St. Louis, Missouri

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

There continues to be significant progress in the treatment of primary biliary cholangitis (PBC) and these Clinical Clips from EASL 2025 have focused on the most impactful data presented at this conference. Dr. Nancy Reau will summarize key advances from Day 2 of EASL 2025 and describe their implications for clinical practice.

Launch Date: May 13, 2025

Release Date: May 13, 2025

Expiration Date: April 30, 2026

FACULTY

Nancy Reau, MD

Section Chief Professor of Medicine

Richard B. Capps MD, Professorship of Hepatology

Rush University Medical Center

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

There continues to be significant progress in the treatment of primary biliary cholangitis (PBC) and these Clinical Clips from EASL 2025 have focused on the most impactful data presented at this conference. Dr. Nancy Reau will summarize key advances from Day 1 of EASL 2025 and describe their implications for clinical practice.

Launch Date: May 13, 2025

Release Date: May 13, 2025

Expiration Date: April 30, 2026

FACULTY

Nancy Reau, MD

Section Chief Professor of Medicine

Richard B. Capps MD, Professorship of Hepatology

Rush University Medical Center

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

In this podcast titled "Emerging Evidence in Myasthenia Gravis: Key Updates from AAN 2025," Dr. Nicholas Silvestri provides healthcare professionals with an actionable update on recent advancements in MG; which features insights from groundbreaking research presented at AAN 2025.

Launch Date: April 30, 2025

Release Date: April 30, 2025

Expiration Date: March 31, 2026

FACULTY

Nicholas Silvestri, MD, FAAN

Professor of Neurology, Associate Dean for Student and Academic Affairs

Department of Neurology

Jacobs School of Medicine & Biomedical Sciences

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Join Dr. Nicholas Silvestri in this 8-minute, special edition podcast series on myasthenia gravis (MG). Today’s podcast titled, The Future of MG Care: Innovations in Diagnostics and Guidelines, looks ahead at emerging technologies and the need for standardized international guidelines to harmonize MG management.

Launch Date: April 28, 2025

Release Date: April 28, 2025

Expiration Date: March 31, 2026

FACULTY

Nicholas Silvestri, MD, FAAN

Professor of Neurology, Associate Dean for Student and Academic Affairs

Department of Neurology

Jacobs School of Medicine & Biomedical Sciences

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Join Dr. Nicholas Silvestri in this 9-minute, special edition podcast series on myasthenia gravis (MG). Today’s podcast titled, Tailoring Treatment: The Role of Serotype Testing, discusses the impact of serotype testing on treatment decisions, including differences in therapeutic approaches for AChR-positive, MuSK-positive, and LRP4-positive patients.

Launch Date: April 24, 2025

Release Date: April 24, 2025

Expiration Date: March 31, 2026

FACULTY

Nicholas Silvestri, MD, FAAN

Professor of Neurology, Associate Dean for Student and Academic Affairs

Department of Neurology

Jacobs School of Medicine & Biomedical Sciences

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Join Dr. Nicholas Silvestri in this 10-minute, special edition podcast series on myasthenia gravis (MG). Today’s podcast titled, Innovations in MG Therapeutics, focuses on the latest therapies, including complement inhibitors and FcRn antagonists, and their application in personalized treatment plans.

Launch Date: April 21, 2025

Release Date: April 21, 2025

Expiration Date: March 31, 2026

FACULTY

Nicholas Silvestri, MD, FAAN

Professor of Neurology, Associate Dean for Student and Academic Affairs

Department of Neurology

Jacobs School of Medicine & Biomedical Sciences

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Join Dr. Nicholas Silvestri in this 8-minute, special edition podcast series on myasthenia gravis (MG). Today’s podcast titled, Advancements in Myasthenia Gravis Diagnosis, highlights the limitations of traditional diagnostic methods and introduces emerging technologies such as high-sensitivity serotype testing and advanced neurophysiological techniques.

Launch Date: April 17, 2025

Release Date: April 17, 2025

Expiration Date: March 31, 2026

FACULTY

Nicholas Silvestri, MD, FAAN

Professor of Neurology, Associate Dean for Student and Academic Affairs

Department of Neurology

Jacobs School of Medicine & Biomedical Sciences

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.